This report describes a pharmacokinetic study and a clinical study of three different formulations of oral tramadol: once-daily tramadol tablets 150 and 200 mg, and normal release tramadol capsules 50 mg 8-hourly. The randomized, open-label, crossover pharmacokinetic study included 22 subjects. The three treatments showed equivalent mean systemic availability of tramadol. The mean relative systemic availabilities (90% confidence intervals) for the once-daily tablets 150 mg and the once-daily tablets 200 mg versus the normal release capsules were 89.6 (83.3-95.8)% and 90.5 (84.6-96.8)%, respectively. The values for the once-daily tablet 150 mg versus the once-daily tablet 200 mg were 99.0 (92.6-105.9)%. The randomized, double-blind, double-dummy, crossover clinical study included 134 patients with moderate osteoarthritic pain. The three treatments showed similar efficacy; they all reduced patients' pain scores from baseline and there were no significant treatment differences in pain scores during treatment. The three treatments were also well tolerated.

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0885-3924(02)00642-5DOI Listing

Publication Analysis

Top Keywords

normal release
12
three treatments
12
once-daily tramadol
8
tramadol tablets
8
release tramadol
8
tramadol capsules
8
pharmacokinetic study
8
clinical study
8
tablets 150
8
study included
8

Similar Publications

High cardiac sympathetic drive and release of the sympathetic cotransmitter neuropeptide Y (NPY) are significant features of congestive heart failure (CHF), in which resting venous NPY levels are known to be associated with mortality. However, whether circulating NPY levels increase during exercise in CHF when they are already elevated is controversial. We sought to establish the dynamics of circulating NPY levels in CHF patients treated with contemporary medical therapy and devices in relationship to indices of performance linked to long-term prognosis.

View Article and Find Full Text PDF

Hydrogels of Poly(2-hydroxyethyl methacrylate) and Poly(N,N-dimethylacrylamide) Interpenetrating Polymer Networks as Dermal Delivery Systems for Dexamethasone.

Pharmaceutics

January 2025

Laboratory on Structure and Properties of Polymers, Faculty of Chemistry and Pharmacy, University of Sofia, 1, J. Bourchier Blvd., 1164 Sofia, Bulgaria.

: This study is an attempt to reveal the potential of two types of interpenetrating polymer network (IPN) hydrogels based on poly(2-hydroxyethyl methacrylate) (PHEMA) and poly(N,N-dimethylacrylamide) (PDMAM). These IPNs were evaluated for their potential for dermal delivery of the hydrophobic drug dexamethasone (DEX). : The two types of IPNs were analyzed for their rheological behavior, swelling characteristics, and drug-loading capacity with DEX.

View Article and Find Full Text PDF

In this study, in order to solve the problems of resource utilization of electrolytic manganese residue and the destruction of natural resources by the over-exploitation of raw materials of traditional ceramics, electrolytic manganese residue (EMR), red mud (RM), and waste soil (WS) were used to prepare self-foaming expanded ceramsite (SEC), and different firing temperatures and four groups with different mixing ratios of these three raw materials were considered. Water absorption, porosity, heavy metal ion leaching, and compressive strength in the cylinder of SEC were evaluated. The chemical composition and microscopic morphology of SEC were investigated by XRD and SEM.

View Article and Find Full Text PDF

Mechanoluminescent (ML) materials emit light by trapping and releasing charge carriers under mechanical stress. However, previous studies do not fully reveal the relationship between emitting light intensity and mechanical stress, thereby affecting the accuracy of stress measurement. This study addresses this gap by systematically investigating ML cylinders with various sizes and loading paths using theoretical analysis and simulations, focusing on the maximum contact stress, equivalent stress distribution, and the relationship between the strain energy density and light intensity at the point of maximum contact stress.

View Article and Find Full Text PDF

The ubiquitin proteasome system (UPS) is implicated in protein homeostasis. One of the proteins involved in this system is HERC1 E3 ubiquitin ligase, which was associated with several processes including the normal development and neurotransmission at the neuromuscular junction (NMJ), autophagy in projection neurons, myelination of the peripheral nervous system, among others. The tambaleante (tbl) mouse model carries the spontaneous mutation Gly483Glu substitution in the HERC1 E3 protein.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!